271 related articles for article (PubMed ID: 26692368)
21. Fingolimod ameliorates the development of experimental autoimmune encephalomyelitis by inhibiting Akt-mTOR axis in mice.
Hou H; Cao R; Miao J; Sun Y; Liu X; Song X; Guo L
Int Immunopharmacol; 2016 Jan; 30():171-178. PubMed ID: 26632437
[TBL] [Abstract][Full Text] [Related]
22. Predictability of FTY720 efficacy in experimental autoimmune encephalomyelitis by in vivo macrophage tracking: clinical implications for ultrasmall superparamagnetic iron oxide-enhanced magnetic resonance imaging.
Rausch M; Hiestand P; Foster CA; Baumann DR; Cannet C; Rudin M
J Magn Reson Imaging; 2004 Jul; 20(1):16-24. PubMed ID: 15221804
[TBL] [Abstract][Full Text] [Related]
23. FTY720 impairs CD8 T-cell function independently of the sphingosine-1-phosphate pathway.
Ntranos A; Hall O; Robinson DP; Grishkan IV; Schott JT; Tosi DM; Klein SL; Calabresi PA; Gocke AR
J Neuroimmunol; 2014 May; 270(1-2):13-21. PubMed ID: 24680062
[TBL] [Abstract][Full Text] [Related]
24. Immunosuppression with FTY720 is insufficient to prevent secondary progressive neurodegeneration in experimental autoimmune encephalomyelitis.
Al-Izki S; Pryce G; Jackson SJ; Giovannoni G; Baker D
Mult Scler; 2011 Aug; 17(8):939-48. PubMed ID: 21459808
[TBL] [Abstract][Full Text] [Related]
25. Prophylactic versus Therapeutic Fingolimod: Restoration of Presynaptic Defects in Mice Suffering from Experimental Autoimmune Encephalomyelitis.
Bonfiglio T; Olivero G; Merega E; Di Prisco S; Padolecchia C; Grilli M; Milanese M; Di Cesare Mannelli L; Ghelardini C; Bonanno G; Marchi M; Pittaluga A
PLoS One; 2017; 12(1):e0170825. PubMed ID: 28125677
[TBL] [Abstract][Full Text] [Related]
26. Variable effects of cyclophosphamide in rodent models of experimental allergic encephalomyelitis.
Mangano K; Nicoletti A; Patti F; Donia M; Malaguarnera L; Signorelli S; Magro G; Muzio V; Greco B; Zaratin P; Meroni P; Zappia M; Nicoletti F
Clin Exp Immunol; 2010 Feb; 159(2):159-68. PubMed ID: 19922500
[TBL] [Abstract][Full Text] [Related]
27. Changes in nociceptive sensitivity and object recognition in experimental autoimmune encephalomyelitis (EAE).
Olechowski CJ; Tenorio G; Sauve Y; Kerr BJ
Exp Neurol; 2013 Mar; 241():113-21. PubMed ID: 23291347
[TBL] [Abstract][Full Text] [Related]
28. Therapeutic activity of malononitrilamides (MNA 279 and MNA 715) on acute and chronic, relapsing, experimental, allergic encephalomyelitis (EAE).
Schorlemmer HU; Bartlett RR
Drugs Exp Clin Res; 1997; 23(5-6):175-81. PubMed ID: 9515227
[TBL] [Abstract][Full Text] [Related]
29. Substrain differences reveal novel disease-modifying gene candidates that alter the clinical course of a rodent model of multiple sclerosis.
deLuca LE; Pikor NB; O'Leary J; Galicia-Rosas G; Ward LA; Defreitas D; Finlay TM; Ousman SS; Osborne LR; Gommerman JL
J Immunol; 2010 Mar; 184(6):3174-85. PubMed ID: 20173032
[TBL] [Abstract][Full Text] [Related]
30. A synthetic androstene derivative and a natural androstene metabolite inhibit relapsing-remitting EAE.
Offner H; Zamora A; Drought H; Matejuk A; Auci DL; Morgan EE; Vandenbark AA; Reading CL
J Neuroimmunol; 2002 Sep; 130(1-2):128-39. PubMed ID: 12225895
[TBL] [Abstract][Full Text] [Related]
31. Oral fingolimod rescues the functional deficits of synapses in experimental autoimmune encephalomyelitis.
Rossi S; Lo Giudice T; De Chiara V; Musella A; Studer V; Motta C; Bernardi G; Martino G; Furlan R; Martorana A; Centonze D
Br J Pharmacol; 2012 Feb; 165(4):861-9. PubMed ID: 21740406
[TBL] [Abstract][Full Text] [Related]
32. Amelioration of experimental autoimmune encephalomyelitis in Lewis rats by FTY720 treatment.
Fujino M; Funeshima N; Kitazawa Y; Kimura H; Amemiya H; Suzuki S; Li XK
J Pharmacol Exp Ther; 2003 Apr; 305(1):70-7. PubMed ID: 12649354
[TBL] [Abstract][Full Text] [Related]
33. High Speed Ventral Plane Videography as a Convenient Tool to Quantify Motor Deficits during Pre-Clinical Experimental Autoimmune Encephalomyelitis.
Zhan J; Yakimov V; Rühling S; Fischbach F; Nikolova E; Joost S; Kaddatz H; Greiner T; Frenz J; Holzmann C; Kipp M
Cells; 2019 Nov; 8(11):. PubMed ID: 31739589
[TBL] [Abstract][Full Text] [Related]
34. Brain penetration of the oral immunomodulatory drug FTY720 and its phosphorylation in the central nervous system during experimental autoimmune encephalomyelitis: consequences for mode of action in multiple sclerosis.
Foster CA; Howard LM; Schweitzer A; Persohn E; Hiestand PC; Balatoni B; Reuschel R; Beerli C; Schwartz M; Billich A
J Pharmacol Exp Ther; 2007 Nov; 323(2):469-75. PubMed ID: 17682127
[TBL] [Abstract][Full Text] [Related]
35. FTY720 sustains and restores neuronal function in the DA rat model of MOG-induced experimental autoimmune encephalomyelitis.
Balatoni B; Storch MK; Swoboda EM; Schönborn V; Koziel A; Lambrou GN; Hiestand PC; Weissert R; Foster CA
Brain Res Bull; 2007 Oct; 74(5):307-16. PubMed ID: 17845905
[TBL] [Abstract][Full Text] [Related]
36. Sphingosine 1-phosphate receptor modulation suppresses pathogenic astrocyte activation and chronic progressive CNS inflammation.
Rothhammer V; Kenison JE; Tjon E; Takenaka MC; de Lima KA; Borucki DM; Chao CC; Wilz A; Blain M; Healy L; Antel J; Quintana FJ
Proc Natl Acad Sci U S A; 2017 Feb; 114(8):2012-2017. PubMed ID: 28167760
[TBL] [Abstract][Full Text] [Related]
37. Effect of dimethyl fumarate on heme oxygenase-1 expression in experimental allergic encephalomyelitis in rats.
Kasarełło K; Jesion A; Tyszkowska K; Matusik K; Czarzasta K; Wrzesień R; Cudnoch-Jedrzejewska A
Folia Neuropathol; 2017; 55(4):325-332. PubMed ID: 29363907
[No Abstract] [Full Text] [Related]
38. Central nervous system expression and PET imaging of the translocator protein in relapsing-remitting experimental autoimmune encephalomyelitis.
Mattner F; Staykova M; Berghofer P; Wong HJ; Fordham S; Callaghan P; Jackson T; Pham T; Gregoire MC; Zahra D; Rahardjo G; Linares D; Katsifis A
J Nucl Med; 2013 Feb; 54(2):291-8. PubMed ID: 23321458
[TBL] [Abstract][Full Text] [Related]
39. Therapeutic effects of 15-deoxyspergualin in acute and chronic relapsing experimental allergic encephalomyelitis (EAE) as models for multiple sclerosis (MS).
Schorlemmer HU; Seiler FR
Drugs Exp Clin Res; 1991; 17(10-11):461-9. PubMed ID: 1841035
[TBL] [Abstract][Full Text] [Related]
40. Beneficial effects of oral administration of C-Phycocyanin and Phycocyanobilin in rodent models of experimental autoimmune encephalomyelitis.
Cervantes-Llanos M; Lagumersindez-Denis N; Marín-Prida J; Pavón-Fuentes N; Falcon-Cama V; Piniella-Matamoros B; Camacho-Rodríguez H; Fernández-Massó JR; Valenzuela-Silva C; Raíces-Cruz I; Pentón-Arias E; Teixeira MM; Pentón-Rol G
Life Sci; 2018 Feb; 194():130-138. PubMed ID: 29287781
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
